For the year ending 2025-12-31, CNP had $19M increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 1,052 | 1,019 | 917 | 1,057 |
| Depreciation and amortization | 1,530 | 1,439 | 1,401 | 1,288 |
| Deferred income taxes | 122 | 221 | 31 | 20 |
| Goodwill impairment and loss from reclassification to held for sale | - | - | - | 0 |
| Goodwill impairment | - | - | - | 0 |
| Loss (gain) on divestitures | - | - | -13 | 303 |
| Loss on sale | -49 | 0 | - | - |
| Loss (gain) on equity securities | -51 | 20 | 31 | -227 |
| Loss (gain) on indexed debt securities | 55 | -14 | -27 | 325 |
| Equity in earnings of unconsolidated affiliates | - | - | 0 | 0 |
| Distributions from unconsolidated affiliates | - | - | 0 | 0 |
| Pension contributions | - | 30 | 32 | 35 |
| Pension and postretirement contributions | 130 | - | - | - |
| Accounts receivable and unbilled revenues, net | 253 | 84 | -423 | 461 |
| Inventory | 17 | -42 | -167 | 259 |
| Taxes receivable | - | 27 | 74 | 19 |
| Accounts payable | -15 | 210 | -302 | 203 |
| Current regulatory assets and liabilities | - | 86 | - | - |
| Other current assets | -146 | - | - | - |
| Net regulatory assets and liabilities | - | - | -1,043 | -234 |
| Non-current regulatory assets and liabilities | - | 644 | - | - |
| Other current liabilities | 64 | - | - | - |
| Other current assets and liabilities | - | -101 | -162 | 5 |
| Other non-current assets | 131 | - | - | - |
| Other non-current assets and liabilities | - | 30 | -72 | -109 |
| Other non-current liabilities | 157 | - | - | - |
| Other operating activities, net | -84 | 14 | 60 | 79 |
| Net cash provided by operating activities | 2,486 | 2,139 | 3,877 | 1,810 |
| Capital expenditures | - | 4,513 | 4,401 | 4,419 |
| Transaction costs related to enable merger (note 4) | - | - | 0 | 0 |
| Cash received related to enable merger | - | - | 0 | 0 |
| Distributions from unconsolidated affiliates in excess of cumulative earnings | - | - | - | 0 |
| Capital expenditures | 4,870 | - | - | - |
| Proceeds from sale of equity securities, net of transaction costs | - | 0 | 0 | 702 |
| Payment for asset acquisition | 357 | - | - | - |
| Proceeds from divestitures | 1,219 | 0 | 144 | 2,075 |
| Other investing activities, net | 8 | -24 | -24 | -14 |
| Net cash provided by (used in) investing activities | -4,016 | -4,489 | -4,233 | -1,628 |
| Increase (decrease) in short-term borrowings, net | - | - | - | 452 |
| Decrease in short-term borrowings, net | -3 | -4 | -10 | - |
| Payment of obligation for finance lease | - | 0 | 0 | 485 |
| Borrowings from revolving credit facilities | - | - | - | 0 |
| Repayments of revolving credit facilities | - | - | - | 0 |
| Payments of commercial paper, net | -2 | -539 | -1,055 | -74 |
| Proceeds from long-term debt and term loans, net | 3,714 | 3,955 | 6,044 | 2,089 |
| Payments of long-term debt and term loans, including make-whole premiums | 1,579 | 1,050 | 3,190 | 1,795 |
| Payment of debt issuance costs | 46 | 35 | 55 | 36 |
| Payment of dividends on common stock | 574 | 522 | 485 | 440 |
| Payment of dividends on preferred stock | 0 | 0 | 50 | 49 |
| Proceeds from issuance of common stock, net | 0 | 494 | - | 0 |
| Proceeds from issuance of series c preferred stock, net | - | - | - | 0 |
| Redemption of series a preferred stock | 0 | 0 | 800 | - |
| Other financing activities, net | 39 | -28 | -25 | -7 |
| Net cash provided by financing activities | 1,549 | 2,271 | 374 | -345 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 19 | -79 | 18 | -163 |
| Cash, cash equivalents and restricted cash at beginning of period | 30 | 109 | 91 | 254 |
| Cash, cash equivalents and restricted cash at end of period | 49 | 30 | 109 | 91 |
CENTERPOINT ENERGY INC (CNP)
CENTERPOINT ENERGY INC (CNP)